— Know what they know.
Not Investment Advice

ACH NYSE

Accendra Health, Inc.
1W: -28.8% 1M: -56.9% 3M: -86.2% YTD: -78.3% 1Y: -95.6% 3Y: -89.9% 5Y: -96.2%
$0.51
-0.05 (-9.43%)
 
Weekly Expected Move ±10.1%
$0 $0 $1 $1 $1
NYSE · Healthcare · Medical - Distribution · Tech Score Strong Sell · Power 24 · $38.7M mcap · 56M float · 2.07% daily turnover · Short 62% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
42.1 / 100
NoneWeakNarrowWide
Primary source: Intangible Assets  ·  ROIC: 4.3%  ·  5Y Avg: 2.4%
Cost Advantage
23
Intangibles
76
Switching Cost
26
Network Effect
35
Scale
45
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ACH shows a Weak competitive edge (42.1/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Intangible Assets. ROIC of 4.3% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$2
Low
$2
Avg Target
$2
High
Based on 2 analysts since Aug 10, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 2Hold: 11Sell: 2Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$1.50
Analysts2
Consensus Change History
DateFieldFromTo
2026-01-08 consensus Buy Hold
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-08-13 UBS — $4 $2 -3 +33.9% $1.12
2026-08-11 Robert W. Baird Eric Coldwell $6 $2 -4 +7.1% $1.40
2026-05-12 UBS — $3 $4 +2 +34.7% $3.34
2026-05-12 Robert W. Baird — $5 $6 +1 +54.2% $3.89
2026-02-22 UBS Kevin Caliendo $4 $3 -1 +14.9% $2.61
2026-01-06 Robert W. Baird Eric Coldwell $10 $5 -5 -44.7% $9.04
2025-11-03 UBS Kevin Caliendo $7 $4 -3 +0.8% $3.97
2025-08-13 UBS Kevin Caliendo $54 $7 -47 +28.0% $5.47
2025-08-11 J.P. Morgan Michael Minchak Initiated $10 — +41.0% $7.09
2025-08-08 Robert W. Baird Eric Coldwell $14 $10 -4 +41.0% $7.09
2024-11-05 Robert W. Baird Eric Coldwell $19 $14 -5 +18.6% $11.80
2024-09-23 Robert W. Baird Eric Coldwell $20 $19 -1 +18.2% $16.07
2024-06-25 Leerink Partners Michael Cherny Initiated $17 — +13.3% $15.00
2024-06-25 Robert W. Baird Eric Coldwell $24 $20 -4 +23.7% $16.17
2024-05-06 Robert W. Baird Eric Coldwell $28 $24 -4 +31.8% $18.21
2024-04-10 Robert W. Baird Eric Coldwell $22 $28 +6 +6.1% $26.38
2022-10-12 Robert W. Baird Eric Coldwell $62 $22 -40 +37.2% $16.03
2022-08-04 Robert W. Baird — Initiated $62 — +181.6% $22.02
2022-08-04 Credit Suisse — Initiated $37 — +14.9% $32.20
2022-05-08 UBS Kevin Caliendo Initiated $54 — +45.1% $37.22

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
Oct 02, 2026
DCF
1
ROE
5
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ACH receives an overall rating of C. Strongest factors: ROE (5/5). Areas of concern: DCF (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-01-22 None ADDED

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 5 Grade D
Profitability
13
Balance Sheet
7
Earnings Quality
78
Growth
12
Value
15
Momentum
20
Safety
15
Cash Flow
20
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ACH scores highest in Earnings Quality (78/100) and lowest in Balance Sheet (7/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
0.32
Distress Zone
Piotroski F-Score
3/9
✗ ✗ ✗ ✓ ✗ ✗ ✓ ✓ ✗
Beneish M-Score
-37.87
Unlikely Manipulator
Ohlson O-Score
-2.73
Bankruptcy prob: 6.1%
Low Risk
Credit Rating
CCC
Score: 17.0/100
Trend: Deteriorating
Earnings Quality
—
OCF/NI: 0.60x
Accruals: -0.1%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ACH scores 0.32, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ACH scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ACH's score of -37.87 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ACH's implied 6.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ACH receives an estimated rating of CCC (score: 17.0/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-0.13x
PEG
-0.00x
P/S
0.01x
P/B
-0.07x
P/FCF
-1.18x
P/OCF
—
EV/EBITDA
8.86x
EV/Revenue
0.77x
EV/EBIT
243.33x
EV/FCF
-9.12x
Earnings Yield
-115.18%
FCF Yield
-85.06%
Shareholder Yield
1.34%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. ACH currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
2.616
NI / EBT
×
Interest Burden
-13.802
EBT / EBIT
×
EBIT Margin
0.003
EBIT / Rev
×
Asset Turnover
0.025
Rev / Assets
×
Equity Multiplier
3.982
Assets / Equity
=
ROE
-1.1%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ACH's ROE of -1.1% is driven by financial leverage (equity multiplier: 3.98x). Note: high leverage means ROE is amplified by debt rather than operational performance. A tax burden ratio of 2.62 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$0.50
Median 1Y
$0.25
5th Pctile
$0.07
95th Pctile
$0.91
Ann. Volatility
79.5%
Analyst Target
$1.50
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Edward A. Pesicka
President & Chief Executive Officer
$1,150,000 $9,560,140 $11,157,809
Andrew G. Long
Executive Vice President, Chief Executive Officer, Products & Healthcare Services
$691,866 $2,879,578 $3,587,180
Perry A. Bernocchi
Executive Vice President, Chief Operating Officer
$644,417 $2,649,205 $3,423,605
Jonathan A. Leon
Executive Vice President & Chief Financial Officer
$572,885 $2,073,293 $2,962,706
Heath H. Galloway
Executive Vice President, General Counsel & Corporate Secretary
$513,731 $1,497,382 $2,294,606

CEO Pay Ratio

69:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $11,157,809
Avg Employee Cost (SGA/emp): $162,133
Employees: 6,500

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
6,500
-51.9% YoY
Revenue / Employee
$424,928
Rev: $2,762,032,000
Profit / Employee
$-169,330
NI: $-1,100,642,000
SGA / Employee
$162,133
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 1.9% 1.4% 0.3% 1.6% 0.8% 0.3% 0.9% 1.4% 3.3% 6.8% 10.2% 10.3% 12.7% 12.1% 10.3% 7.5% 7.3% -1.6% -4.9% -1.1% -1.12%
ROA 0.5% 0.3% 0.1% 0.4% 0.2% 0.1% 0.3% 0.4% 0.8% 1.9% 2.9% 3.0% 3.5% 3.7% 3.0% 2.1% 2.0% -0.5% -1.4% -0.3% -0.28%
ROIC 1.2% 1.1% 0.6% 1.0% 0.7% 0.3% 0.6% 1.3% 2.4% 5.1% 7.4% 9.6% 11.9% 13.2% 12.6% 9.1% 4.3% 1.6% -4.2% 4.3% 4.26%
ROCE 4.9% 3.9% 3.2% 4.1% 3.7% 3.0% 3.9% 4.7% 6.5% 9.9% 11.4% 18.6% 19.4% 21.9% 21.1% 13.5% 9.3% 4.2% 1.4% 0.6% 0.58%
Gross Margin 7.0% 7.1% 6.4% 6.0% 6.6% 5.6% 10.6% 4.8% 10.0% 10.6% 12.4% 13.9% 9.9% 14.2% 11.0% 9.0% 46.2% 45.6% 44.3% 43.0% 42.95%
Operating Margin 1.6% 1.8% 1.1% -0.5% 0.5% 0.4% 2.3% 1.5% 3.9% 6.9% 5.6% 4.2% 5.7% 7.4% 4.4% 0.5% 3.8% 7.3% 3.6% -5.7% -5.73%
Net Margin 1.0% 0.5% 0.2% 0.1% 0.1% 0.0% 0.9% 0.6% 1.9% 3.1% 3.0% 0.4% 2.5% 3.1% 1.4% -1.9% -21.6% -7.9% -1.0% -14.5% -14.52%
EBITDA Margin 8.5% 7.1% 7.2% 5.2% 7.6% 6.2% 10.0% 6.0% 10.5% 11.1% 10.8% 12.8% 10.2% 13.7% 10.5% 6.4% 12.8% 7.0% 12.4% 2.1% 2.06%
FCF Margin 2.0% 0.8% 1.8% 1.8% 3.6% 4.4% 3.8% 5.3% 5.6% 7.1% 8.3% 9.1% 10.1% 9.6% 10.5% 8.7% 8.3% 8.4% 2.2% -8.4% -8.43%
OCF Margin 5.9% 4.9% 6.2% 6.6% 8.1% 8.7% 7.8% 8.0% 7.7% 8.4% 9.5% 9.8% 10.9% 10.4% 11.4% 10.4% 10.1% 10.9% 5.3% -6.8% -6.82%
ROA 3Y Avg snapshot only -3.12%
ROIC 3Y Avg snapshot only 3.16%
ROIC Economic snapshot only 4.26%
Cash ROA snapshot only -8.56%
Cash ROIC snapshot only -14.76%
CROIC snapshot only -18.25%
NOPAT Margin snapshot only 1.97%
Pretax Margin snapshot only -4.36%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 39.14%
SBC / Revenue snapshot only 0.19%
Valuation
Metric Trend Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio — — — — — — — — — — — — — — — — 0.34 -1.47 -0.12 -0.87 -0.129
P/S Ratio — — — — — — — — — — — — — — — — 0.00 0.01 0.00 0.10 0.015
P/B Ratio — — — — — — — — — — — — — — — — -1.63 -1.50 -0.38 -0.48 -0.070
P/FCF — — — — — — — — — — — — — — — — 0.04 0.06 0.12 -1.18 -1.176
P/OCF — — — — — — — — — — — — — — — — 0.03 0.05 0.05 — —
EV/EBITDA — — — — — — — — — — — — — — — — 0.13 0.23 0.47 8.86 8.860
EV/Revenue — — — — — — — — — — — — — — — — 0.01 0.02 0.03 0.77 0.769
EV/EBIT — — — — — — — — — — — — — — — — 0.20 0.42 1.21 243.33 243.332
EV/FCF — — — — — — — — — — — — — — — — 0.16 0.24 1.37 -9.12 -9.125
Earnings Yield — — — — — — — — — — — — — — — — 2.9% -67.9% -8.1% -1.2% -1.15%
FCF Yield — — — — — — — — — — — — — — — — 25.1% 16.1% 8.4% -85.1% -85.06%
EV/Gross Profit snapshot only 1.715
Acquirers Multiple snapshot only 30.904
Shareholder Yield snapshot only 1.34%
Leverage & Solvency
Metric Trend Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 0.78 0.77 0.78 0.70 0.74 0.74 0.79 0.74 0.79 0.85 1.01 0.93 1.08 1.07 1.08 0.87 0.86 0.58 0.49 0.41 0.407
Quick Ratio 0.48 0.48 0.49 0.42 0.46 0.47 0.45 0.42 0.46 0.52 0.67 0.58 0.69 0.72 0.74 0.48 0.84 0.50 0.43 0.30 0.297
Debt/Equity 2.11 2.02 2.00 1.86 1.93 1.85 1.68 1.70 1.86 1.52 1.64 1.55 1.54 1.35 1.47 1.59 -5.11 -4.85 -4.67 -3.23 -3.233
Net Debt/Equity 1.76 1.76 1.71 1.63 1.66 1.62 1.54 1.50 1.64 1.33 1.30 1.22 1.14 0.96 0.99 1.28 — — — — —
Debt/Assets 0.53 0.52 0.51 0.50 0.51 0.50 0.48 0.47 0.48 0.45 0.46 0.46 0.44 0.42 0.43 0.41 0.54 0.91 0.90 0.85 0.845
Debt/EBITDA 7.89 8.47 8.84 7.66 8.35 8.65 7.19 6.66 5.78 4.13 3.73 2.58 2.35 2.03 2.17 2.87 0.10 0.20 0.51 7.75 7.752
Net Debt/EBITDA 6.59 7.37 7.55 6.72 7.16 7.54 6.57 5.88 5.09 3.60 2.96 2.04 1.73 1.44 1.46 2.31 0.10 0.17 0.43 7.72 7.719
Interest Coverage 1.31 1.01 0.80 1.12 1.05 0.88 1.25 1.43 2.03 3.25 4.13 5.94 6.45 7.02 6.74 5.30 5.15 3.41 1.73 0.07 0.068
Equity Multiplier 4.00 3.91 3.90 3.72 3.81 3.71 3.53 3.59 3.86 3.38 3.59 3.36 3.49 3.22 3.41 3.90 -9.40 -5.32 -5.20 -3.83 -3.825
Cash Ratio snapshot only 0.011
Debt Service Coverage snapshot only 1.855
Cash to Debt snapshot only 0.004
FCF to Debt snapshot only -0.125
Defensive Interval snapshot only 41.6 days
Efficiency & Turnover
Metric Trend Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.90 0.93 0.98 0.94 0.89 0.87 0.88 0.93 0.98 1.12 1.26 1.54 1.66 1.73 1.68 1.44 2.11 1.35 0.65 0.02 0.025
Inventory Turnover 7.33 7.99 8.58 8.88 7.79 8.24 8.05 8.80 8.84 10.65 11.73 13.64 14.27 15.40 15.08 11.92 18.97 12.72 5.83 0.12 0.118
Receivables Turnover 20.44 30.91 25.78 24.51 20.46 28.65 21.46 22.23 26.47 37.20 31.61 36.40 61.09 69.53 63.71 51.90 85.05 67.22 26.89 1.25 1.253
Payables Turnover 11.56 12.32 14.34 13.34 12.05 12.36 12.41 12.34 23.70 14.49 17.89 15.44 95.33 17.06 33.11 12.58 77.39 11.67 19.80 0.13 0.128
DSO 18 12 14 15 18 13 17 16 14 10 12 10 6 5 6 7 4 5 14 291 291.4 days
DIO 50 46 43 41 47 44 45 41 41 34 31 27 26 24 24 31 19 29 63 3097 3097.5 days
DPO 32 30 25 27 30 30 29 30 15 25 20 24 4 21 11 29 5 31 18 2860 2860.4 days
Cash Conversion Cycle 36 28 31 29 34 27 33 28 40 19 22 13 28 8 19 9 19 3 58 528 528.4 days
Fixed Asset Turnover snapshot only 8.660
Operating Cycle snapshot only 3388.8 days
Cash Velocity snapshot only 346.000
Capital Intensity snapshot only 0.796
Growth (YoY)
Metric Trend Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 5.5% 12.1% 20.1% 5.5% 0.1% -7.0% -11.4% -2.2% 6.5% 24.2% 39.6% 60.7% 64.2% 51.3% 33.8% -2.6% -35.3% -60.4% -80.3% -99.1% -99.09%
Net Income -26.4% -51.7% -88.0% 2.6% -54.8% -74.7% 1.8% -10.4% 2.9% 20.1% 10.0% 6.5% 3.0% 86.3% 4.4% -27.2% -70.1% -1.1% -1.2% -1.1% -1.07%
EPS -43.3% -52.7% -88.3% -21.4% -51.9% -75.2% 1.9% -4.3% 3.0% 22.0% 10.5% 6.5% 3.1% 87.5% 4.4% -27.2% 1.6% -1.6% -3.2% -1.6% -1.64%
FCF 9.4% -78.7% -48.7% -44.9% 78.9% 4.4% 86.9% 1.8% 65.0% 1.0% 2.0% 1.7% 2.0% 1.0% 69.9% -6.4% -46.8% -65.6% -95.8% -1.0% -1.01%
EBITDA 0.2% -19.4% -22.7% -2.7% -10.5% -7.7% 7.9% 4.6% 29.4% 80.7% 86.8% 1.5% 1.3% 90.1% 62.8% -12.3% -40.7% -71.8% -89.2% -99.2% -99.24%
Op. Income -14.8% -31.5% -54.2% -17.7% -42.5% -70.4% -20.1% 19.1% 1.9% 11.7% 8.1% 5.5% 3.2% 1.2% 51.6% -10.3% -48.8% -82.1% -97.8% -99.5% -99.52%
OCF Growth snapshot only -1.01%
Asset Growth snapshot only -99.01%
Equity Growth snapshot only -1.01%
Debt Growth snapshot only -97.94%
Shares Change snapshot only -88.74%
Dividend Growth snapshot only -1.00%
Growth (CAGR)
Metric Trend Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 16.8% 21.6% 18.7% 9.7% 4.4% -1.2% -2.7% 0.9% 4.0% 9.0% 14.1% 18.4% 20.5% 20.4% 18.3% 15.2% 4.2% -9.4% -28.3% -75.8% -75.77%
Revenue 5Y 1.4% 3.0% 5.2% 6.0% 6.8% 5.4% 6.0% 8.5% 11.2% 15.7% 15.7% 15.7% 14.7% 12.7% 11.5% 9.9% 3.6% -5.0% -17.1% -57.0% -57.01%
EPS 3Y 84.8% 39.0% -50.7% 23.8% -20.8% -47.8% -35.5% -21.8% 2.8% 39.1% 56.7% 78.3% 99.5% 1.2% 2.3% 73.8% 2.5% — — — —
EPS 5Y — — — — — — — 33.9% 64.6% 72.6% 31.5% 68.8% 52.4% 43.7% 26.4% 21.3% 64.0% — — — —
Net Income 3Y 1.0% 48.6% -47.4% 32.3% -15.7% -44.1% -31.5% -18.2% 9.1% 37.1% 54.6% 90.6% 91.2% 1.1% 2.2% 70.0% 66.6% — — — —
Net Income 5Y — — — — — — — 38.8% 70.6% 77.2% 35.1% 73.3% 56.1% 47.0% 29.8% 24.6% 9.0% — — — —
EBITDA 3Y 35.0% 32.3% 20.5% 2.5% -2.1% -5.7% -5.8% -1.4% 5.1% 10.4% 15.9% 36.2% 38.0% 46.9% 48.6% 31.5% 20.3% -1.1% -31.1% -74.5% -74.50%
EBITDA 5Y 29.0% 27.3% 23.0% 36.7% 25.5% 14.0% 17.0% 19.8% 23.3% 31.0% 28.6% 22.9% 22.5% 23.6% 20.5% 15.9% 9.4% -6.4% -22.9% -55.8% -55.80%
Gross Profit 3Y 76.9% 72.2% 42.9% 5.5% -0.5% -5.7% -5.3% -5.3% 1.4% 7.6% 14.7% 38.4% 41.3% 49.4% 51.3% 36.8% 26.4% 7.9% -20.2% -54.8% -54.79%
Gross Profit 5Y 48.2% 49.2% 43.7% 95.4% 48.6% 23.9% 30.3% 39.3% 44.2% 51.9% 42.9% 27.4% 25.6% 26.5% 21.8% 16.4% 10.7% -3.1% -16.2% -38.6% -38.62%
Op. Income 3Y — — — 43.5% -5.9% -38.7% -31.4% -10.1% 12.4% 37.1% 49.4% 85.6% 91.7% 1.0% 1.2% 91.0% 84.5% 70.3% -32.4% -69.6% -69.56%
Op. Income 5Y — — — — — — — — — — — 87.1% 59.2% 44.8% 34.8% 33.6% 25.2% 0.0% -35.3% -51.2% -51.22%
FCF 3Y — 40.9% -6.3% -11.0% 2.2% 18.5% 19.1% 34.9% 47.8% 32.7% 42.6% 62.3% 1.1% 1.8% 1.1% 93.7% 37.7% 12.2% -40.1% — —
FCF 5Y 34.2% -12.7% 4.9% -8.1% 5.1% 20.2% 23.1% — — 98.3% 35.9% 40.4% 39.2% 46.8% 54.0% 44.5% 38.6% 10.4% -27.0% — —
OCF 3Y 13.7% 4.0% 2.2% 3.0% 3.2% 6.1% 3.3% 3.8% 7.7% 7.7% 19.4% 30.4% 47.3% 55.4% 45.3% 33.8% 12.1% -2.3% -37.0% — —
OCF 5Y 3.2% -3.7% 1.9% -1.8% 2.4% 5.5% 3.7% 15.6% 15.2% 17.5% 15.4% 20.5% 20.7% 22.1% 24.7% 17.7% 11.8% -0.6% -24.3% — —
Assets 3Y 4.2% 3.9% 2.7% 2.2% 2.6% 2.6% 1.0% -0.9% -1.0% -1.8% -0.9% -1.4% -2.4% -2.2% -1.4% 1.5% -73.1% -77.0% -76.9% -77.9% -77.89%
Assets 5Y 0.4% 0.2% 0.9% 1.1% 1.3% 0.7% 0.8% 0.6% 1.0% 0.9% 0.6% 0.2% 0.4% 0.7% 0.9% 1.2% -54.3% -58.7% -58.8% -59.8% -59.81%
Equity 3Y 11.0% 10.7% 12.1% 12.8% 12.4% 13.5% 13.5% 11.2% 0.1% 4.1% 2.3% 3.0% 2.2% 4.4% 3.1% -0.2% — — — — —
Book Value 3Y 1.7% 3.6% 4.9% 5.5% 5.7% 6.0% 6.9% 6.4% -5.7% 5.6% 3.7% -3.7% 6.6% 7.0% 5.4% 2.1% — — — — —
Dividend 3Y -31.0% -29.5% -26.5% -12.3% -9.8% -10.4% -11.3% -10.6% -10.9% -4.1% 1.9% -15.0% -6.6% -5.4% 0.3% 6.8% 1.1% 67.1% -34.6% — —
Growth Quality
Metric Trend Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.13 0.20 0.36 0.82 0.94 0.58 0.46 0.74 0.85 0.88 0.83 0.68 0.60 0.54 0.57 0.67 0.29 0.04 0.00 0.07 0.067
Earnings Stability 0.22 0.35 0.31 0.47 0.45 0.41 0.35 0.24 0.38 0.33 0.22 0.43 0.48 0.56 0.51 0.51 0.27 0.06 0.02 0.04 0.044
Margin Stability 0.36 0.34 0.40 0.46 0.54 0.62 0.61 0.60 0.61 0.58 0.63 0.72 0.75 0.68 0.71 0.73 0.74 0.75 0.82 0.03 0.030
Rev. Growth Consistency 1.00 0.50 0.50 0.50 1.00 0.00 0.00 0.00 1.00 0.50 0.50 0.50 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.50 0.00 0.00 0.50 0.00 0.50 0.50 1.00 0.50 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0
Earnings Persistence 0.89 0.50 0.50 0.99 0.50 0.50 0.50 0.96 0.50 0.50 0.50 0.50 0.50 0.50 0.98 0.89 0.50 0.20 0.20 0.20 0.200
Earnings Smoothness 0.70 0.30 0.00 0.97 0.25 0.00 0.05 0.89 0.00 0.00 0.00 0.00 0.00 0.40 0.96 0.69 0.00 — — — —
ROE Trend -0.00 -0.01 -0.03 -0.01 -0.01 -0.02 -0.01 -0.00 0.02 0.06 0.10 0.09 0.10 0.08 0.04 0.02 — — — — —
Gross Margin Trend -0.01 -0.02 -0.03 -0.01 -0.01 -0.02 -0.00 -0.00 0.01 0.03 0.03 0.05 0.05 0.05 0.04 0.02 0.02 -0.00 -0.01 0.33 0.332
FCF Margin Trend -0.01 -0.03 -0.01 -0.01 0.02 0.02 0.01 0.03 0.03 0.05 0.05 0.05 0.06 0.04 0.04 0.02 0.00 -0.00 -0.07 -0.17 -0.173
Sustainable Growth Rate -8.1% -8.4% -8.3% -7.4% -7.7% -8.1% -6.0% -5.8% -4.1% -0.0% 3.2% 5.0% 7.5% 7.0% 4.0% 1.5% -2.3% — — — —
Internal Growth Rate — — — — — — — — — — 0.9% 1.5% 2.1% 2.2% 1.1% 0.4% — — — — —
Cash Flow Quality
Metric Trend Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 11.42 13.07 67.80 14.76 34.66 85.56 27.17 19.57 8.94 4.87 4.22 5.09 5.23 4.94 6.47 7.20 10.55 -30.80 -2.43 0.60 0.597
FCF/OCF 0.34 0.15 0.30 0.28 0.44 0.51 0.49 0.66 0.72 0.85 0.87 0.93 0.93 0.92 0.92 0.84 0.82 0.77 0.42 1.24 1.237
FCF/Net Income snapshot only 0.738
OCF/EBITDA snapshot only -0.785
CapEx/Revenue 3.9% 4.1% 4.3% 4.8% 4.6% 4.3% 4.0% 2.7% 2.1% 1.2% 1.2% 0.7% 0.8% 0.8% 0.9% 1.6% 1.8% 2.5% 3.0% 1.6% 1.61%
CapEx/Depreciation snapshot only 0.193
Accruals Ratio -0.05 -0.04 -0.06 -0.06 -0.07 -0.07 -0.07 -0.07 -0.07 -0.07 -0.09 -0.12 -0.15 -0.14 -0.16 -0.13 -0.19 -0.15 -0.05 -0.00 -0.001
Sloan Accruals snapshot only 0.067
Cash Flow Adequacy snapshot only -4.225
Dividends & Buybacks
Metric Trend Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield — — — — — — — — — — — — — — — — 3.8% 2.1% 62.4% 0.0% 0.00%
Dividend/Share $6.70 $7.03 $6.22 $6.63 $6.30 $6.09 $5.29 $5.79 $5.43 $5.62 $5.61 $4.34 $4.09 $4.46 $5.31 $4.95 $34.77 $18.94 $1.42 $0.00 $0.00
Payout Ratio 5.3% 7.1% 24.9% 5.7% 10.4% 25.0% 7.4% 5.2% 2.3% 1.0% 68.2% 51.3% 41.0% 42.3% 61.8% 80.5% 1.3% — — — —
FCF Payout Ratio 1.4% 3.5% 1.2% 1.4% 68.2% 57.3% 55.4% 39.7% 35.0% 24.1% 18.6% 10.9% 8.4% 9.3% 10.3% 13.3% 15.3% 13.0% 7.4% — —
Total Payout Ratio 7.8% 10.5% 38.2% 5.7% 10.4% 25.0% 7.4% 7.8% 3.4% 1.5% 1.0% 1.4% 1.2% 1.2% 1.5% 1.4% 2.6% — — — —
Div. Increase Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 — —
Chowder Number — — — — — — — — — — — — — — — — 3.81 1.58 -0.35 — —
Buyback Yield — — — — — — — — — — — — — — — — 3.6% 3.6% 14.3% 1.3% 1.34%
Net Buyback Yield — — — — — — — — — — — — — — — — 71.3% 1.2% 4.8% 1.3% 1.34%
Total Shareholder Return — — — — — — — — — — — — — — — — 4.6% 3.3% 5.5% 1.3% 1.34%
DuPont Factors
Metric Trend Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.41 0.35 0.14 0.40 0.27 0.20 0.36 0.35 0.43 0.49 0.51 0.41 0.41 0.39 0.34 0.32 0.23 -0.16 -113.53 2.62 2.616
Interest Burden (EBT/EBIT) 0.37 0.40 0.32 0.38 0.33 0.23 0.27 0.35 0.46 0.59 0.67 0.54 0.59 0.60 0.58 0.65 0.60 0.46 0.01 -13.80 -13.802
EBIT Margin 0.03 0.03 0.02 0.03 0.03 0.02 0.03 0.03 0.04 0.06 0.07 0.09 0.09 0.09 0.09 0.07 0.07 0.05 0.03 0.00 0.003
Asset Turnover 0.90 0.93 0.98 0.94 0.89 0.87 0.88 0.93 0.98 1.12 1.26 1.54 1.66 1.73 1.68 1.44 2.11 1.35 0.65 0.02 0.025
Equity Multiplier 4.00 3.96 3.92 3.77 3.90 3.81 3.71 3.65 3.83 3.54 3.56 3.47 3.66 3.30 3.49 3.62 3.58 3.28 3.48 3.98 3.982
Per Share
Metric Trend Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $1.26 $0.99 $0.25 $1.17 $0.60 $0.24 $0.72 $1.12 $2.40 $5.61 $8.23 $8.46 $9.97 $10.53 $8.59 $6.16 $26.29 $-6.13 $-18.51 $-3.94 $-3.94
Book Value/Share $68.37 $73.09 $73.05 $75.15 $75.06 $73.58 $77.78 $79.79 $71.24 $84.42 $80.81 $84.10 $82.83 $89.46 $85.52 $79.90 $-5.56 $-6.01 $-6.06 $-7.18 $-7.18
Tangible Book/Share $45.41 $49.74 $48.32 $52.28 $48.50 $67.15 $50.71 $54.35 $43.90 $77.05 $50.72 $50.90 $55.34 $82.08 $58.40 $61.64 $-23.59 $-23.80 $-23.47 $-24.21 $-24.21
Revenue/Share $241.17 $265.17 $275.47 $261.52 $256.82 $241.24 $249.33 $273.15 $278.81 $327.06 $363.87 $438.95 $479.76 $498.26 $486.96 $427.35 $2733.26 $1739.71 $852.70 $34.51 $34.51
FCF/Share $4.85 $1.99 $5.01 $4.81 $9.24 $10.63 $9.56 $14.56 $15.53 $23.31 $30.19 $39.88 $48.38 $47.86 $51.28 $37.34 $226.88 $145.36 $19.12 $-2.91 $-2.91
OCF/Share $14.34 $12.88 $16.95 $17.32 $20.92 $20.88 $19.42 $21.96 $21.49 $27.34 $34.71 $43.02 $52.12 $52.04 $55.56 $44.31 $277.42 $188.90 $45.02 $-2.35 $-2.35
Cash/Share $23.80 $19.16 $21.23 $17.11 $20.65 $17.46 $11.37 $15.73 $15.96 $16.57 $27.28 $27.24 $33.76 $35.32 $41.14 $24.70 $0.42 $3.68 $4.39 $0.10 $0.10
EBITDA/Share $18.24 $17.46 $16.54 $18.22 $17.37 $15.76 $18.22 $20.35 $22.91 $31.10 $35.60 $50.52 $54.49 $59.50 $57.95 $44.29 $284.92 $147.99 $55.33 $3.00 $3.00
Debt/Share $143.97 $147.79 $146.16 $139.59 $145.09 $136.31 $131.04 $135.44 $132.53 $128.47 $132.69 $130.12 $127.79 $120.97 $125.94 $126.97 $28.42 $29.12 $28.30 $23.22 $23.22
Net Debt/Share $120.17 $128.63 $124.93 $122.48 $124.44 $118.86 $119.68 $119.71 $116.58 $111.90 $105.42 $102.89 $94.03 $85.65 $84.81 $102.27 $28.00 $25.45 $23.91 $23.12 $23.12
Academic Models
Metric Trend Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 0.323
Altman Z-Prime snapshot only -2.917
Piotroski F-Score 5 4 4 7 6 4 8 6 9 9 9 9 8 9 8 5 6 4 4 3 3
Beneish M-Score -2.53 -4.94 -2.35 -3.18 -2.74 -2.48 -3.07 -2.60 -2.87 -2.55 -2.93 -2.97 -3.20 -4.88 -3.49 -2.43 -45.05 -60.67 -40.70 -37.87 -37.875
Ohlson O-Score snapshot only -2.733
Net-Net WC snapshot only $-31.12
EVA snapshot only $-70224910.00
Credit
Metric Trend Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only CCC
Credit Score 25.28 24.40 22.41 25.33 25.33 23.10 25.80 27.33 34.24 40.37 45.99 55.56 57.83 62.15 60.00 50.96 89.52 86.00 80.79 17.03 17.029
Credit Grade snapshot only 17
Credit Trend snapshot only -33.931
Implied Spread (bps) snapshot only 1200.000
Industry Credit Rank snapshot only 4
Sector Credit Rank snapshot only 7

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms